<SEC-DOCUMENT>0001140361-22-018655.txt : 20220511
<SEC-HEADER>0001140361-22-018655.hdr.sgml : 20220511
<ACCEPTANCE-DATETIME>20220511161606
ACCESSION NUMBER:		0001140361-22-018655
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220511
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220511
DATE AS OF CHANGE:		20220511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADMA BIOLOGICS, INC.
		CENTRAL INDEX KEY:			0001368514
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				562590442
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36728
		FILM NUMBER:		22913918

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446
		BUSINESS PHONE:		(201) 478-5552

	MAIL ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	R&R ACQUISITION VI, INC
		DATE OF NAME CHANGE:	20060707
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10037508_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:adma="http://admabiologics.com/20220511" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_fcc16de834c547bd87eb3f38c0034516" contextRef="c20220511to20220511" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_546df22608804557b72a0881a4b052d5" contextRef="c20220511to20220511">0001368514</ix:nonNumeric><ix:nonNumeric name="dei:TradingSymbol" id="Fact_835ed43d8bd545a08b6bb7352eb246fc" contextRef="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember">0</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="adma-20220511.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220511to20220511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001368514</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-11</xbrli:startDate><xbrli:endDate>2022-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001368514</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-11</xbrli:startDate><xbrli:endDate>2022-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001368514</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">adma:PreferredSharePurchaseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-11</xbrli:startDate><xbrli:endDate>2022-05-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_9cecc975af8742b48d408f8cf79975a8" contextRef="c20220511to20220511">8-K</ix:nonNumeric></div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <span style="text-decoration: underline;"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_3fb195caf9e54def9f03c607df40a7ec" contextRef="c20220511to20220511" format="ixt:datemonthdayyearen">May 11, 2022</ix:nonNumeric></span></div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_cc90e1ebf60544219f56108ce02f4fcc" contextRef="c20220511to20220511">ADMA BIOLOGICS, INC.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ed90c91ce0714c1fb8bb4750bbe93add" contextRef="c20220511to20220511" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_3fa7a0e0561f4dbeb121d9216a3fde44" contextRef="c20220511to20220511">001-36728</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_53920910fefd46c9bfab588c84d749db" contextRef="c20220511to20220511">56-2590442</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: bottom;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: bottom;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: bottom;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_7b1052ca2ebe4a35b6b4bcec97c5c7b2" contextRef="c20220511to20220511">465 State Route 17</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_33fe96b673f34c57a1138f46366724cd" contextRef="c20220511to20220511">Ramsey</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_2b84ddaa727f44feb266c9c06e042f87" contextRef="c20220511to20220511" format="ixt-sec:stateprovnameen">New Jersey</ix:nonNumeric></div>
            </td>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 2%;" colspan="1"><br />
            </td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_f207dfed7ddc47b89db06ac45cb074c8" contextRef="c20220511to20220511">07446</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(Address of principal executive offices)</div>
            </td>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 2%;" colspan="1"><br />
            </td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_e43b66a41aef48e896502efefe409ac5" contextRef="c20220511to20220511">201</ix:nonNumeric>)
        <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_853ab52c4c1045cf9c5205c8f964feae" contextRef="c20220511to20220511">478-5552</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report.)</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
        (<span style="font-style: italic;">see</span> General Instruction A.2. below):</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_0fe44937211d436ca41298e00fa6b17a" contextRef="c20220511to20220511" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: auto; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_0067919335a74ea4bc366d441a573020" contextRef="c20220511to20220511" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: auto; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_f05a56f0f3304993a60c5e8082a895e8" contextRef="c20220511to20220511" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: auto; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_f35d644d6b4e4f589a1f50b2bed14ced" contextRef="c20220511to20220511" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </div>
              </td>

    <td style="width: auto; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">Title of each class</div>
            </td>

    <td style="width: 34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">Trading Symbol(s)</div>
            </td>

    <td style="width: 33.34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">Name of each exchange on which</div>
              <div style="text-align: center;">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_bdb03dfa13c94b59a0625c26cad4f00a" contextRef="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember">Common Stock</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_567b01f731c943fda978c1c7e721ee30" contextRef="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember">ADMA</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_c80829a64cad4de78d507a2eb4f9abd9" contextRef="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember" format="ixt-sec:exchnameen">Nasdaq Global Market</ix:nonNumeric><br />
            </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_4e2531f6ec9a4b54b5e92bf064423be0" contextRef="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember">Preferred Share Purchase Rights</ix:nonNumeric><br />
            </td>

    <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">-</div>
            </td>

    <td style="width: 33.34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_1418755abf83496884d7e053b7cf016d" contextRef="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember" format="ixt-sec:exchnameen">Nasdaq Global Market</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter)
        or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_50f82e07973844dfa03ff55715efb1eb" contextRef="c20220511to20220511" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <!--PROfilePageNumberReset%Num%2%%%-->
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Results of Operations and Financial Condition</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On May 11, 2022, ADMA Biologics, Inc. issued a press release announcing its financial results for the three months ended March 31, 2022 and providing a
        business update. A copy of the press release is furnished herewith as Exhibit 99.1.*</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 22.5pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Exhibits</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><span style="text-decoration: underline;">Exhibit No.</span></div>
            </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><span style="text-decoration: underline;">Description</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">
              <div style="text-align: left;"><a href="brhc10037508_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">ADMA Biologics, Inc. Press Release, dated May 11, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">
              <div style="text-align: left;">104</div>
            </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Cover Page Interactive Data File (embedded with the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">* The information in Item 2.02 of this Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
        Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in
        such a filing.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">2</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center;"><span style="text-decoration: underline;">SIGNATURE</span></div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">May 11, 2022</div>
            </td>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3">
              <div style="text-align: left;">ADMA Biologics, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="3"><br />
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left;">By:</div>
            </td>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: left;">/s/ Brian Lenz</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Name:</div>
            </td>

    <td style="width: 42%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Brian Lenz</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Title:</div>
            </td>

    <td style="width: 42%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Executive Vice President and Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">3</span> </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10037508_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--> <font style="font-size: 10pt; font-family: 'Times New Roman';"> </font>
  <hr align="center" noshade="noshade" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div>
      <div style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><img height="53" width="192" src="image0.jpg"></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold; background-color: rgb(255, 255, 255); font-variant: normal; text-transform: none;">ADMA Biologics Announces
        First Quarter 2022 Financial Results and Provides Business Update</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">First Quarter 2022 Total Revenues Were Approximately $29.1 Million, an 81% Increase Over First Quarter 2021</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Increases Full Year 2022 Total Revenue Guidance to $130 Million or More From $125 Million</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Gross Margin Growth and Narrowing Net Losses Expected Throughout 2022 and Beyond</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">RAMSEY, N.J. and BOCA RATON, Fla., May 11, 2022</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> -- ADMA Biologics, Inc. (Nasdaq: ADMA) (&#8220;ADMA&#8221; or the &#8220;Company&#8221;), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty
          plasma-derived biologics, today announced its first quarter 2022 financial results and provided a business update.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;Year-to-date execution for ADMA&#8217;s intravenous immunoglobulin product portfolio has exceeded
        internal expectations and serves as the basis for the increased 2022 total revenue financial guidance to $130 million or more,&#8221; said Adam Grossman, President and Chief Executive Officer of ADMA. &#8220;We continue to gain confidence that
        above-expectation trends for our higher margin products, notably ASCENIV&#8482;, will prove durable, which is improving visibility on the Company&#8217;s pathway to profitability. Over the remainder of 2022, we expect to deliver significant revenue growth and
        market share gains for our product portfolio, improve margins as operating leverage is realized, and continue to prioritize the exploration of strategic alternatives, to maximize stockholder value.&#8221;</font></div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We are very encouraged with our first quarter financial results, particularly when considering some of the non-recurring dynamics that occurred during the quarter,&#8221; said
      Brian Lenz, ADMA&#8217;s Chief Financial Officer, and General Manager, ADMA BioCenters. &#8220;The reported first quarter net loss includes a $6.7 million one-time charge related to the Hayfin debt refinancing, which, among other things, extended the Company&#8217;s
      interest-only period at a lowered cost of capital and provided significant non-dilutive capital. Further, we elected to extend the previously scheduled, and otherwise routine shutdown at the Boca Raton manufacturing facility to enable the completion
      of certain projects forecasted for later in the year. The facility&#8217;s production schedule is anticipated to progress on a normal course moving forward, and as such, this cost headwind is anticipated to normalize over the coming quarters.&#160; Finally, we
      incurred additional, non-operational expenses related to the ongoing strategic review process. Accounting for these non-operational quarterly occurrences, we are encouraged by the continued operational efficiencies being unlocked and look forward to
      expanding on these trends as we accelerate towards profitability.&#8221;</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Lenz continued, &#8220;The Company is well-capitalized, holding approximately $70 million in cash and cash equivalents at the end of the first quarter.&#160; Further, as a result
      of our continued revenue growth in the first quarter of 2022, we have achieved the revenue milestone under the Hayfin loan agreement to draw down an additional $25 million in non-dilutive funds at the Company&#8217;s option.&#8221;</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">First Quarter 2022 and Recent Achievements:</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z33a17e7548a64b0d8dd255072a533f7f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Executed Financially:</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; Achieved first quarter 2022 total revenues of $29.1 million, as compared to $16.0 million during the first quarter of 2021, an increase of $13.1 million, or approximately 81%.&#160; Due to a favorable product mix, as we continue to
                expand our customer base for both BIVIGAM&#174; and ASCENIV, ADMA realized a gross margin of approximately 13% during the first quarter of 2022, resulting from continued supply chain operating efficiencies. This improved gross margin compared to
                the first quarter of 2021 was achieved despite our election to extend the previously scheduled and otherwise routine plant shutdown that occurred during the quarter, which resulted in additional costs to complete certain projects that had
                been forecasted later in the year.&#160; Excluding the costs associated with the extended facility shutdown, the Company estimates first quarter 2022 gross margins would have been closer to 20% in a normalized production quarter.</font></div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z43ebd3f0ee4843a2ab50df7467d8cdc0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Driving Greater Adoption of Higher Margin Product:</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> ADMA is particularly encouraged with the continued physician adoption and utilization of its proprietary immune globulin product ASCENIV. Elevated product demand trends have sustained throughout April and
                into May, lending incremental confidence that ASCENIV&#8217;s upside will prove durable and margin mix will continue to favorably evolve throughout 2022 and beyond.</font></div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z337d25defea842629c82d59e357bf261" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Expiration Dating Extension:</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> Announced the United States Food and Drug Administration&#8217;s (&#8220;FDA&#8221;) approval to extend the expiration dating from 24 to 36 months for both its ASCENIV and BIVIGAM drug product stored at 2-8&#176;C. The extension of ASCENIV&#8217;s and
                BIVIGAM&#8217;s shelf life to 36 months dating is a meaningful enhancement of each product&#8217;s go-to market offering as it should provide for a more efficient net working capital cycle for the Company, as well as allow for more versatile
                utilization and inventory management by providers. As a result of this approval, in the second quarter of 2022, ADMA anticipates realizing certain, previously reserved for product at an outsized margin contribution.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z879fc10e4456414ea12609686e65f04d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">On-Track BioCenters Expansion: </font><font style="font-size: 10pt; font-family: 'Times New Roman';">At present, our BioCenters segment has ten plasma collection centers under its corporate umbrella: five centers are FDA-licensed, two additional collection centers are operational and collecting plasma, and three centers
                in various stages of construction. The Company remains on track to have ten BioCenters locations FDA-licensed by year-end 2023 and in the same period forecasts raw material plasma supply self-sufficiency. We anticipate our strong plasma
                supply position will support our upwardly revised production and revenue forecasts.</font></div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zafde2b873ee345c791ee5ca57f524831" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Refinanced Senior Secured Term Loan:</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> Refinanced the Company&#8217;s senior secured term loan with Hayfin Capital Management (&#8220;Hayfin&#8221;), which among other things, lowered the effective cost of capital, extended the interest-only period by three years to March
                2027 and, importantly, enabled the Company to raise significant non-dilutive capital.&#160; We have achieved the revenue milestone under the Hayfin loan agreement to draw down an additional $25 million in non-dilutive funds at the Company&#8217;s
                discretion.</font></div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zbfe83bb3614345a9ad043af4392691f6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Ongoing Strategic Review:</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> ADMA continues to evaluate a variety of strategic alternatives through its ongoing engagement with Morgan Stanley. The Company will communicate material developments as required by the U.S. Securities and Exchange Commission.&#160; The
                exploration of strategic opportunities remains a corporate priority for ADMA.</font></div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022 &amp; Long-Term Financial Guidance:</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z19bebbe6f1e74497a522bf7945b5d807" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">2022 Financial Guidance: </font><font style="font-size: 10pt; font-family: 'Times New Roman';">Enabled by the strong start to the year, ADMA increases 2022 total revenue guidance to $130 million or more, upwardly revised from $125 million.&#160; ADMA reiterates expectations to grow revenues and gross profits and narrow net losses
                as 2022 progresses.</font></div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf43b02a90a7245f8b4a553d6da0ac0a7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">2024-2025 Financial Guidance:</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; We believe that ADMA is on track to potentially generate $250 million in topline revenue in 2024, and $300 million thereafter.&#160; At this revenue level, and based upon current assumptions, we anticipate potentially achieving
                40-50% corporate gross margins and 20-30% net income margins.&#160; These assumptions translate to potential annual gross profit and net income of $100-150 million and $50-100 million respectively during the 2024-2025 time-period and beyond.</font></div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 11pt; font-weight: bold;">First Quarter 2022 Financial Results:</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Total revenues for the first quarter ended March 31, 2022 were $29.1
        million, as compared to $16.0 million during the first quarter of 2021, an increase of $13.1 million, or approximately 81%. The revenue growth for the first quarter of 2022, compared to the first quarter of 2021, was favorably impacted by the
        continued commercial ramp up of our intravenous immunoglobulin (IVIG) product portfolio and expanding our customer base for BIVIGAM and ASCENIV.</font></div>
    <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Gross profit for the first quarter of 2022 was $3.7 million, compared to a gross loss of $1.7 million for the first quarter of 2021. Gross profit
      growth during the first quarter was driven by a favorable contribution from higher margin products, notably ASCENIV, which was partially offset by a meaningful quarter-over-quarter and year-over-year increase in overhead costs attributable to an
      extended, routine plant shutdown in the first quarter of 2022.&#160; The Company anticipates the facility&#8217;s production schedule will proceed on a standard course moving forward, with overhead costs normalizing in the coming quarters.</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Consolidated net loss for the quarter ended March 31, 2022 was $25.0
        million, or $(0.13) per basic and diluted share, compared to a consolidated net loss of $18.4 million, or $(0.16) per basic and diluted share, for the quarter ended March 31, 2021.&#160; The reported net loss for the quarter ended March 31, 2022
        includes non-recurring charges from the extinguishment of debt related to the Hayfin debt transaction of $6.7 million and professional services fees of $1.3 million related to the strategic review process.</font></div>
    <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">As of March 31, 2022, ADMA had working capital of $208.2 million, primarily consisting of $139.1 million of inventory, cash and cash equivalents of
      $69.5 million and net accounts receivable of $25.6 million, partially offset by an aggregate of $31.6 million of accounts payable and accrued expenses and other current liabilities, as compared to working capital of $178.4 million as of December 31,
      2021.</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Conference Call Information</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">To access the conference call on May 11, 2022 at 4:30PM ET, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes
      prior to the start time and refer to conference ID 1783606. A live audio webcast of the call will be available under &#8220;Events &amp; Webcasts&#8221; in the investor section of the Company&#8217;s website, https://ir.admabiologics.com/events-webcasts. An archived
      webcast will be available on the Company&#8217;s website approximately two hours after the event.</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About BIVIGAM<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">BIVIGAM (immune globulin intravenous, human &#8211; 10% liquid) is a plasma-derived, polyclonal, intravenous immune globulin (IVIG). BIVIGAM was approved by the FDA in May 2019
        and is indicated for the treatment of primary humoral immunodeficiency (PI), including, but not limited to the following group of genetic disorders: X-linked and congenital agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich
        syndrome and severe combined immunodeficiency. BIVIGAM contains a broad range of antibodies similar to those found in normal human plasma. These antibodies are directed against bacteria and viruses and help to protect PI patients against serious
        infections. BIVIGAM is a purified, sterile, ready-to-use preparation of concentrated human Immunoglobulin antibodies.&#160;&#160; Certain data and other information about BIVIGAM&#174; or ADMA Biologics and its products can be found on the Company&#8217;s website at
        www.admabiologics.com.</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About ASCENIV&#8482;</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ASCENIV (immune globulin intravenous, human &#8211; slra 10% liquid) is a plasma-derived, polyclonal, intravenous immune globulin (IVIG). ASCENIV was approved by the FDA in
        April 2019 and is indicated for the treatment of primary humoral immunodeficiency (PI), also known as primary immune deficiency disease (PIDD), in adults and adolescents (12 to 17 years of age). ASCENIV is manufactured using ADMA&#8217;s unique, patented
        plasma donor screening methodology and tailored plasma pooling design, which blends normal source plasma and respiratory syncytial virus (RSV) plasma obtained from donors tested using the Company&#8217;s proprietary microneutralization assay. ASCENIV
        contains naturally occurring polyclonal antibodies, which are proteins that are used by the body&#8217;s immune system to neutralize microbes, such as bacteria and viruses and prevent against infection and disease. ASCENIV is protected by U.S. Patents:
        9,107,906, 9,714,283 and 9,815,886.&#160;&#160; Certain data and other information about ASCENIV&#8482; or ADMA Biologics and its products can be found on the Company&#8217;s website at www.admabiologics.com.</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About ADMA BioCenters</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ADMA BioCenters is an FDA-licensed facility specializing in the collection of human plasma used to make special medications for the treatment and prevention of diseases.
      Managed by a team of experts who have decades of experience in the specialized field of plasma collection, ADMA BioCenters provides a safe, professional and pleasant donation environment. ADMA BioCenters strictly follows FDA regulations and guidance
      and enforces cGMP (current good manufacturing practices) in all of its facilities. For more information about ADMA BioCenters, please visit www.admabiocenters.com.</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About ADMA Biologics, Inc. (ADMA)</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the
      treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the
      treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM&#174; (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV&#8482; (immune globulin intravenous, human &#8211; slra 10%
      liquid) for the treatment of PI; and NABI-HB&#174; (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification
      facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA&#8217;s
      mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient
      populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 and European Patent No. 3375789, among
      others, related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com. </div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">This press release contains &#8220;forward-looking statements&#8221; pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995,
      about ADMA Biologics, Inc. and its subsidiaries (collectively, &#8220;our&#8221;, &#8220;ADMA&#8221; or the &#8220;Company&#8221;). Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or
      achievements, and may contain such words as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;forecasts,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;targets,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or, in each case, their negative, or words
      or expressions of similar meaning. These forward-looking statements also include, but are not limited to, statements about ADMA&#8217;s future results of operations (including, but not limited to, total 2022 revenues) and pro forma results; the success of
      ASCENIV&#8482;, particularly with physicians, providers and patients, and market share of the Company&#8217;s product portfolio; the benefits of extending the routine shutdown at the Boca Raton manufacturing facility; our production schedule and its impact on
      financial performance; the operational and financial benefits of expiration dating extension for ASCENIV and BIVIGAM&#174;; the ability to obtain FDA approval of its plasma collection centers and the associated timing in connection therewith; the ability
      to achieve source plasma self-sufficiency and the associated timing in connection therewith, as well as benefits thereof; and the Company&#8217;s ongoing discussions with Morgan Stanley regarding the evaluation of strategic alternatives. Actual events or
      results may differ materially from those described in this press release due to a number of important factors. Current and prospective security holders are cautioned that there also can be no assurance that the forward-looking statements included in
      this press release will prove to be accurate. Except to the extent required by applicable laws or rules, ADMA does not undertake any obligation to update any forward-looking statements or to announce revisions to any of the forward-looking
      statements. Forward-looking statements are subject to many risks, uncertainties and other factors that could cause our actual results, and the timing of certain events, to differ materially from any future results expressed or implied by the
      forward-looking statements, including, but not limited to, the risks and uncertainties described in our filings with the SEC, including our most recent reports on Form 10-K, 10-Q and 8-K, and any amendments thereto.</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMPANY CONTACT:</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Skyler Bloom</div>
    <font style="font-weight: normal;"> </font>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Senior Director, Business Development and Corporate Strategy | 201-478-5552 | sbloom@admabio.com</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INVESTOR RELATIONS CONTACT:</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Michelle Pappanastos</div>
    <font style="font-weight: normal;"> </font>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Senior Managing Director, Argot Partners | 212-600-1902 | <u>michelle@argotpartners.com</u></font></div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-size: 10pt; font-family: 'Times New Roman';"><img height="53" width="192" src="image0.jpg"></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">ADMA BIOLOGICS, INC. AND
      SUBSIDIARIES</div>
    <font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">CONSOLIDATED STATEMENTS OF
      OPERATIONS</div>
    <font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">(Unaudited)</div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z2caa2e5e0e4442f5bf905efc401949e3" class="cfttable">

        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; font-weight: bold;">Three Months Ended March 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-weight: bold;"> 2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">REVENUES:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Product revenue</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>29,067,385</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>16,012,910</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">License revenue</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>35,708</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>35,708</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-weight: bold;">Total revenues</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>29,103,093</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>16,048,618</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Cost of product revenue</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>25,441,046</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>17,770,122</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-weight: bold;">Gross profit (loss)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>3,662,047</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(1,721,504</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">OPERATING EXPENSES:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Research and development</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>624,111</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>987,649</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Plasma center operating expenses</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>3,974,589</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>2,242,343</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Amortization of intangible assets</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>178,838</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>178,838</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Selling, general and administrative</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>13,699,575</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>10,033,915</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-weight: bold;">Total operating expenses</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>18,477,113</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>13,442,745</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">LOSS FROM OPERATIONS</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>(14,815,066</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>(15,164,249</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">OTHER INCOME (EXPENSE):</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Interest income</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>33,068</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>22,059</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Interest expense</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>(3,389,038</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>(3,195,750</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Loss on extinguishment of debt</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(6,669,941</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Other expense</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>(166,880</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div>(42,001</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-weight: bold;">Other expense, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(10,192,791</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(3,215,692</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">NET LOSS</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(25,007,857</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(18,379,941</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">BASIC AND DILUTED LOSS PER COMMON SHARE</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(0.13</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>(0.16</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-weight: bold;">Basic and Diluted</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>195,871,932</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>115,661,937</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">ADMA BIOLOGICS, INC. AND
      SUBSIDIARIES</div>
    <font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">CONDENSED CONSOLIDATED
      BALANCE SHEETS</div>
    <font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zc064fc4543294191892def409c7f9c0b" class="cfttable">

        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';" rowspan="2" colspan="1">&#160;&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell" rowspan="2">&#160;&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2" rowspan="2">
            <div style="text-align: center; font-weight: bold;">March 31,</div>
            <div style="text-align: center; font-weight: bold;"> 2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell" rowspan="2">&#160;&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell" rowspan="2">&#160;&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2" rowspan="2">
            <div style="text-align: center; font-weight: bold;">December 31,</div>
            <div style="text-align: center; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">ASSETS</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';" colspan="2">
            <div style="text-align: center;">(Unaudited)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman';" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Current assets:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Cash and cash equivalents</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>69,504,946</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>51,089,118</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Accounts receivable, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>25,629,625</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>28,576,857</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Inventories</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>139,146,311</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>124,724,091</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Prepaid expenses and other current assets</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>5,519,301</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>4,339,245</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt;">Total current assets</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>239,800,183</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>208,729,311</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Property and equipment, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>53,220,480</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>50,935,074</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Intangible assets, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>1,549,930</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>1,728,768</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Goodwill</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>3,529,509</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>3,529,509</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Right to use assets</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>7,106,642</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>7,262,658</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Deposits and other assets</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>2,825,748</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>4,067,404</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">TOTAL ASSETS</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>308,032,492</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>276,252,724</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">LIABILITIES AND STOCKHOLDERS' EQUITY</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Current liabilities:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Accounts payable</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>14,115,135</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>12,429,409</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Accrued expenses and other current liabilities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>16,654,540</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>17,214,988</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Current portion of deferred revenue</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>142,834</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>142,834</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Current portion of lease obligations</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>654,003</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>591,084</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt;">Total current liabilities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>31,566,512</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>30,378,315</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Senior notes payable, net of discount</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>138,423,052</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>94,866,239</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Deferred revenue, net of current portion</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>1,940,156</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>1,975,865</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">End of term fee</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>1,500,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Lease obligations, net of current portion</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>7,284,079</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>7,462,388</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Other non-current liabilities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>385,628</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>397,351</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">TOTAL LIABILITIES</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>181,099,427</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>135,080,158</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">COMMITMENTS AND CONTINGENCIES</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">STOCKHOLDERS' EQUITY</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Preferred Stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
            <div>-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Common Stock - voting, $0.0001 par value, 300,000,000 shares authorized, 196,347,529 and 195,813,817 shares issued and outstanding</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>19,635</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div>19,581</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Additional paid-in capital</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>564,034,008</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>553,265,706</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Accumulated deficit</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>(437,120,578</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>(412,112,721</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">TOTAL STOCKHOLDERS' EQUITY</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>126,933,065</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div>141,172,566</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-size: 10pt; font-family: 'Times New Roman'; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>308,032,492</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div>$</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div>276,252,724</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font> </div>
    <div style="font-size: 10pt; font-family: 'Times New Roman';">
      <hr align="center" noshade="noshade" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt; font-family: 'Times New Roman';"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>adma-20220511.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://admabiologics.com/20220511" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:adma="http://admabiologics.com/20220511" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="adma-20220511_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="adma-20220511_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="adma-20220511_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://admabiologics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="PreferredSharePurchaseRightsMember" id="adma_PreferredSharePurchaseRightsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>adma-20220511_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://admabiologics.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="adma-20220511.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://admabiologics.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="definition: ClassOfStockDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="adma-20220511.xsd#adma_PreferredSharePurchaseRightsMember" xlink:label="PreferredSharePurchaseRightsMember" xlink:title="PreferredSharePurchaseRightsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="PreferredSharePurchaseRightsMember" xlink:title="definition: ClassOfStockDomain to PreferredSharePurchaseRightsMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>adma-20220511_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="adma-20220511.xsd#adma_PreferredSharePurchaseRightsMember" xlink:label="PreferredSharePurchaseRightsMember" xlink:title="PreferredSharePurchaseRightsMember" />
    <link:label xlink:type="resource" xlink:label="adma_PreferredSharePurchaseRightsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="adma_PreferredSharePurchaseRightsMember_lbl1" xml:lang="en-US" id="adma_PreferredSharePurchaseRightsMember_lbl1">Preferred Share Purchase Rights [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredSharePurchaseRightsMember" xlink:to="adma_PreferredSharePurchaseRightsMember_lbl1" xlink:title="label: PreferredSharePurchaseRightsMember to adma_PreferredSharePurchaseRightsMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>adma-20220511_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://admabiologics.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="adma-20220511.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://admabiologics.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="presentation: ClassOfStockDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="adma-20220511.xsd#adma_PreferredSharePurchaseRightsMember" xlink:label="PreferredSharePurchaseRightsMember" xlink:title="PreferredSharePurchaseRightsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="PreferredSharePurchaseRightsMember" xlink:title="presentation: ClassOfStockDomain to PreferredSharePurchaseRightsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !3 2P# 2(  A$! Q$!_\0
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M/9$ 3 ;X6/\ "XZ?GTKP+3=0GTO4K>^MFVRP.&'OZC\:]'_X7!_U!S_W^_\
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M[/KV5^QRD<;2RI&@RSL%4>YJ?4-/N=+OY;*[0)/$<.H.<<9ZTFG_ /(3M?\
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LE@N+IY8P/X\$_GUKN" >HS117AXM)578]_!2<J2;%Z=****YCK"BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140618905926680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 11, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 11,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ADMA BIOLOGICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2590442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">465 State Route 17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ramsey<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-5552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001368514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADMA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=adma_PreferredSharePurchaseRightsMember', window );">Preferred Share Purchase Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Share Purchase Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=adma_PreferredSharePurchaseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=adma_PreferredSharePurchaseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>brhc10037508_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:adma="http://admabiologics.com/20220511"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adma-20220511.xsd" xlink:type="simple"/>
    <context id="c20220511to20220511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001368514</identifier>
        </entity>
        <period>
            <startDate>2022-05-11</startDate>
            <endDate>2022-05-11</endDate>
        </period>
    </context>
    <context id="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001368514</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-11</startDate>
            <endDate>2022-05-11</endDate>
        </period>
    </context>
    <context id="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001368514</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">adma:PreferredSharePurchaseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-11</startDate>
            <endDate>2022-05-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220511to20220511"
      id="Fact_fcc16de834c547bd87eb3f38c0034516">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220511to20220511"
      id="Fact_546df22608804557b72a0881a4b052d5">0001368514</dei:EntityCentralIndexKey>
    <dei:TradingSymbol
      contextRef="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember"
      id="Fact_835ed43d8bd545a08b6bb7352eb246fc">0</dei:TradingSymbol>
    <dei:DocumentType
      contextRef="c20220511to20220511"
      id="Fact_9cecc975af8742b48d408f8cf79975a8">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220511to20220511"
      id="Fact_3fb195caf9e54def9f03c607df40a7ec">2022-05-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220511to20220511"
      id="Fact_cc90e1ebf60544219f56108ce02f4fcc">ADMA BIOLOGICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220511to20220511"
      id="Fact_ed90c91ce0714c1fb8bb4750bbe93add">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220511to20220511"
      id="Fact_3fa7a0e0561f4dbeb121d9216a3fde44">001-36728</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220511to20220511"
      id="Fact_53920910fefd46c9bfab588c84d749db">56-2590442</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220511to20220511"
      id="Fact_7b1052ca2ebe4a35b6b4bcec97c5c7b2">465 State Route 17</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220511to20220511"
      id="Fact_33fe96b673f34c57a1138f46366724cd">Ramsey</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220511to20220511"
      id="Fact_2b84ddaa727f44feb266c9c06e042f87">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220511to20220511"
      id="Fact_f207dfed7ddc47b89db06ac45cb074c8">07446</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220511to20220511"
      id="Fact_e43b66a41aef48e896502efefe409ac5">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220511to20220511"
      id="Fact_853ab52c4c1045cf9c5205c8f964feae">478-5552</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220511to20220511"
      id="Fact_0fe44937211d436ca41298e00fa6b17a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220511to20220511"
      id="Fact_0067919335a74ea4bc366d441a573020">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220511to20220511"
      id="Fact_f05a56f0f3304993a60c5e8082a895e8">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220511to20220511"
      id="Fact_f35d644d6b4e4f589a1f50b2bed14ced">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_bdb03dfa13c94b59a0625c26cad4f00a">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_567b01f731c943fda978c1c7e721ee30">ADMA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220511to20220511_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_c80829a64cad4de78d507a2eb4f9abd9">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember"
      id="Fact_4e2531f6ec9a4b54b5e92bf064423be0">Preferred Share Purchase Rights</dei:Security12bTitle>
    <dei:SecurityExchangeName
      contextRef="c20220511to20220511_StatementClassOfStockAxis_PreferredSharePurchaseRightsMember"
      id="Fact_1418755abf83496884d7e053b7cf016d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220511to20220511"
      id="Fact_50f82e07973844dfa03ff55715efb1eb">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  "@JM4'#AEZC\!   \ @  #P
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M=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @  H*K5"0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    (  *"JU1ED'F2&0$
M ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@
MIAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1
M?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI
M>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UP
MZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T
M,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^
MD<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#
M%     @  H*K5 =!36*!    L0   !               ( !     &1O8U!R
M;W!S+V%P<"YX;6Q02P$"% ,4    "  "@JM4$=]]7NX    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  "@JM4
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    (  *"JU1TZX=7C@0  (<3   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  "@JM4
MGZ ;\+$"  #B#   #0              @ '1#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    (  *"JU27BKL<P    !,"   +              "  :T/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    (  *"JU0<.&7J/P$  #P"   /
M      "  980  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  "@JM4)!Z;
MHJT   #X 0  &@              @ $"$@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  "@JM499!YDAD!  #/ P  $P
M    @ 'G$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   Q
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10037508_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://admabiologics.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10037508_8k.htm">brhc10037508_8k.htm</File>
    <File>adma-20220511.xsd</File>
    <File>adma-20220511_def.xml</File>
    <File>adma-20220511_lab.xml</File>
    <File>adma-20220511_pre.xml</File>
    <File>brhc10037508_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10037508_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "adma-20220511_def.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10037508_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "adma-20220511_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adma-20220511_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "adma-20220511.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 35,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "adma",
   "nsuri": "http://admabiologics.com/20220511",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037508_8k.htm",
      "contextRef": "c20220511to20220511",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://admabiologics.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037508_8k.htm",
      "contextRef": "c20220511to20220511",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "adma_PreferredSharePurchaseRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Share Purchase Rights [Member]"
       }
      }
     },
     "localname": "PreferredSharePurchaseRightsMember",
     "nsuri": "http://admabiologics.com/20220511",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://admabiologics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-22-018655-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-018655-xbrl.zip
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M!"YP-IE"^,):+V]BE):-1[](0_M :I9/O3!79)Q 0V[WQ'TFP2LG_IDY*CA
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M^?W'39H$WR"A"&<7K5ZGVPI@%N$898N+UIJV 8T0:GW\\/-/[W]IMS_!#!+
M8!S,GH+KJT_#ASE*.)0&XX=[_A$&[SI=\2_X@V 0$Q0O8+LM=N:HK^?BQPQ0
M&/!),WJ^H>BBM61L=1Z&CX^/G<=!!Y-%V.]V>^$_GV\GT1*FH(TRRD 6P5;
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M4J5. 1VDE'"K)R1F4ES42YP:HY35BF(I:XYK:=@?1,#*H^9L&WEWU3[4:YH
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M/M-^>E@OS<-.]QJ=]P=1,@8.SJXE=)$T5AO?G,E</LG=/V4YS(TR;=U(>3>
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MFL .9+<;&@0-(=Q<9Z)R8\9[,>;0GIM2:-\X"7<PV0_TWS,?E"&@9R(%&<%
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M'P*VG3BW&O $#]XP.P']!8;WA9V5W'X(][%G4XPZ+]D68?,52A',!'Y'?G-
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M=.=\[O >;GXHN^-*,S[%$F%I<W,+[A9G$&$?0A[S\:C,/2>[YT=[FC#J65-
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M.4D23Q22D^Q+XO(R*8]O<:74F;#>!'].@?.! <>BRM2CKN/Q.#7[S&?Q'%E
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MS-8[FMXT-:M;Q2#2DV2AW*:6DFHEU1N3:K/=TDS;Q/8M6RW5)3=['IE\4T[
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MFQ!$T/:__^OSAT'DW;(?QNDD@!_^/U!+ 0(4 Q0    (  *"JU2 I%1ZT ,
M #L1   1              "  0    !A9&UA+3(P,C(P-3$Q+GAS9%!+ 0(4
M Q0    (  *"JU0/CE^P^P8  -Y$   5              "  ?\#  !A9&UA
M+3(P,C(P-3$Q7V1E9BYX;6Q02P$"% ,4    "  "@JM4W[S?=R0*   4:@
M%0              @ $M"P  861M82TR,#(R,#4Q,5]L86(N>&UL4$L! A0#
M%     @  H*K5)Y[ZEH*!P  8TT  !4              ( !A!4  &%D;6$M
M,C R,C U,3%?<')E+GAM;%!+ 0(4 Q0    (  *"JU2O0'5F/!,   >%   3
M              "  <$<  !B<FAC,3 P,S<U,#A?.&LN:'1M4$L! A0#%
M  @  H*K5,$M1,X$,P  )-H" !<              ( !+C   &)R:&,Q,# S
E-S4P.%]E>#DY+3$N:'1M4$L%!@     &  8 C@$  &=C      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
